Search

everythinglearnresearchcommunity

for

Search:↓

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Alpha mangostin may protect certain breast cancer cells by activating the p53 pathway.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

Tailored medication preparation and ongoing education are crucial for effective treatments.

African plants may help treat cancer by boosting immunity and protecting cells.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Promising cancer treatments were found, but the manufacturer closed.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

MK-5108 is safe and shows potential against tumors, especially alone.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Taxol damages hair growth cells, causing hair loss.